Recombinant protein advancements revolutionize assay development
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Accelerating Science
The latest advancements in mass spectrometry accelerating discovery in health, environment, and food analysis
Explore feature
Clinical Diagnostics
The tools and tech innovating infectious disease diagnostics and antimicrobial resistance detection
Explore feature
